2025-01-012025-12-312025-12-31false11708928PIRIL SIDERAS AESTHETICS & SKIN SANCTUARY LTD2026-04-1486220falseiso4217:GBPxbrli:pure117089282024-12-31117089282025-12-31117089282025-01-012025-12-31117089282023-12-31117089282024-12-31117089282024-01-012024-12-3111708928bus:SmallEntities2025-01-012025-12-3111708928bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3111708928bus:FullAccounts2025-01-012025-12-3111708928bus:PrivateLimitedCompanyLtd2025-01-012025-12-3111708928core:WithinOneYear2025-12-3111708928core:AfterOneYear2025-12-3111708928core:WithinOneYear2024-12-3111708928core:AfterOneYear2024-12-311170892812025-01-012025-12-3111708928core:ShareCapital2025-12-3111708928core:SharePremium2025-12-3111708928core:RevaluationReserve2025-12-3111708928core:OtherReservesSubtotal2025-12-3111708928core:RetainedEarningsAccumulatedLosses2025-12-3111708928core:ShareCapital2024-12-3111708928core:SharePremium2024-12-3111708928core:RevaluationReserve2024-12-3111708928core:OtherReservesSubtotal2024-12-3111708928core:RetainedEarningsAccumulatedLosses2024-12-3111708928core:LandBuildings2025-12-3111708928core:PlantMachinery2025-12-3111708928core:Vehicles2025-12-3111708928core:FurnitureFittings2025-12-3111708928core:OfficeEquipment2025-12-3111708928core:NetGoodwill2025-12-3111708928core:IntangibleAssetsOtherThanGoodwill2025-12-3111708928core:ListedExchangeTraded2025-12-3111708928core:UnlistedNon-exchangeTraded2025-12-3111708928core:LandBuildings2024-12-3111708928core:PlantMachinery2024-12-3111708928core:Vehicles2024-12-3111708928core:FurnitureFittings2024-12-3111708928core:OfficeEquipment2024-12-3111708928core:NetGoodwill2024-12-3111708928core:IntangibleAssetsOtherThanGoodwill2024-12-3111708928core:ListedExchangeTraded2024-12-3111708928core:UnlistedNon-exchangeTraded2024-12-3111708928core:LandBuildings2025-01-012025-12-3111708928core:PlantMachinery2025-01-012025-12-3111708928core:Vehicles2025-01-012025-12-3111708928core:FurnitureFittings2025-01-012025-12-3111708928core:OfficeEquipment2025-01-012025-12-3111708928core:NetGoodwill2025-01-012025-12-3111708928core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3111708928core:ListedExchangeTraded2025-01-012025-12-3111708928core:UnlistedNon-exchangeTraded2025-01-012025-12-3111708928core:MoreThanFiveYears2025-01-012025-12-3111708928core:Non-currentFinancialInstruments2025-12-3111708928core:Non-currentFinancialInstruments2024-12-3111708928dpl:CostSales2025-01-012025-12-3111708928dpl:DistributionCosts2025-01-012025-12-3111708928core:LandBuildings2025-01-012025-12-3111708928core:PlantMachinery2025-01-012025-12-3111708928core:Vehicles2025-01-012025-12-3111708928core:FurnitureFittings2025-01-012025-12-3111708928core:OfficeEquipment2025-01-012025-12-3111708928dpl:AdministrativeExpenses2025-01-012025-12-3111708928core:NetGoodwill2025-01-012025-12-3111708928core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3111708928dpl:GroupUndertakings2025-01-012025-12-3111708928dpl:ParticipatingInterests2025-01-012025-12-3111708928dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3111708928core:ListedExchangeTraded2025-01-012025-12-3111708928dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3111708928core:UnlistedNon-exchangeTraded2025-01-012025-12-3111708928dpl:CostSales2024-01-012024-12-3111708928dpl:DistributionCosts2024-01-012024-12-3111708928core:LandBuildings2024-01-012024-12-3111708928core:PlantMachinery2024-01-012024-12-3111708928core:Vehicles2024-01-012024-12-3111708928core:FurnitureFittings2024-01-012024-12-3111708928core:OfficeEquipment2024-01-012024-12-3111708928dpl:AdministrativeExpenses2024-01-012024-12-3111708928core:NetGoodwill2024-01-012024-12-3111708928core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111708928dpl:GroupUndertakings2024-01-012024-12-3111708928dpl:ParticipatingInterests2024-01-012024-12-3111708928dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3111708928core:ListedExchangeTraded2024-01-012024-12-3111708928dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3111708928core:UnlistedNon-exchangeTraded2024-01-012024-12-3111708928core:NetGoodwill2025-12-3111708928core:IntangibleAssetsOtherThanGoodwill2025-12-3111708928core:LandBuildings2025-12-3111708928core:PlantMachinery2025-12-3111708928core:Vehicles2025-12-3111708928core:FurnitureFittings2025-12-3111708928core:OfficeEquipment2025-12-3111708928core:AfterOneYear2025-12-3111708928core:WithinOneYear2025-12-3111708928core:ListedExchangeTraded2025-12-3111708928core:UnlistedNon-exchangeTraded2025-12-3111708928core:ShareCapital2025-12-3111708928core:SharePremium2025-12-3111708928core:RevaluationReserve2025-12-3111708928core:OtherReservesSubtotal2025-12-3111708928core:RetainedEarningsAccumulatedLosses2025-12-3111708928core:NetGoodwill2024-12-3111708928core:IntangibleAssetsOtherThanGoodwill2024-12-3111708928core:LandBuildings2024-12-3111708928core:PlantMachinery2024-12-3111708928core:Vehicles2024-12-3111708928core:FurnitureFittings2024-12-3111708928core:OfficeEquipment2024-12-3111708928core:AfterOneYear2024-12-3111708928core:WithinOneYear2024-12-3111708928core:ListedExchangeTraded2024-12-3111708928core:UnlistedNon-exchangeTraded2024-12-3111708928core:ShareCapital2024-12-3111708928core:SharePremium2024-12-3111708928core:RevaluationReserve2024-12-3111708928core:OtherReservesSubtotal2024-12-3111708928core:RetainedEarningsAccumulatedLosses2024-12-3111708928core:NetGoodwill2023-12-3111708928core:IntangibleAssetsOtherThanGoodwill2023-12-3111708928core:LandBuildings2023-12-3111708928core:PlantMachinery2023-12-3111708928core:Vehicles2023-12-3111708928core:FurnitureFittings2023-12-3111708928core:OfficeEquipment2023-12-3111708928core:AfterOneYear2023-12-3111708928core:WithinOneYear2023-12-3111708928core:ListedExchangeTraded2023-12-3111708928core:UnlistedNon-exchangeTraded2023-12-3111708928core:ShareCapital2023-12-3111708928core:SharePremium2023-12-3111708928core:RevaluationReserve2023-12-3111708928core:OtherReservesSubtotal2023-12-3111708928core:RetainedEarningsAccumulatedLosses2023-12-3111708928core:AfterOneYear2025-01-012025-12-3111708928core:WithinOneYear2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111708928core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3111708928core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3111708928core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3111708928core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3111708928core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3111708928core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3111708928core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3111708928core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3111708928core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3111708928core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3111708928core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3111708928bus:Director12025-01-012025-12-3111708928core:FurnitureFittingsToolsEquipment2024-12-3111708928core:FurnitureFittingsToolsEquipment2025-12-3111708928core:FurnitureFittingsToolsEquipment2025-01-012025-12-31

PIRIL SIDERAS AESTHETICS & SKIN SANCTUARY LTD

(formerly PS AESTHETICS CLINIC LTD)

Registered Number
11708928
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

PIRIL SIDERAS AESTHETICS & SKIN SANCTUARY LTD
Company Information
for the year from 1 January 2025 to 31 December 2025

Director

EREL-SIDERAS, Piril

Registered Address

3 Maple Leaf Villas Brookfield Lane West
Cheshunt
Waltham Cross
EN8 0QP

Registered Number

11708928 (England and Wales)
PIRIL SIDERAS AESTHETICS & SKIN SANCTUARY LTD
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3614767
614767
Current assets
Stocks47,6055,350
Debtors31,74017,991
Cash at bank and on hand15,08642,475
54,43165,816
Creditors amounts falling due within one year5(8,084)(10,420)
Net current assets (liabilities)46,34755,396
Total assets less current liabilities46,96156,163
Creditors amounts falling due after one year6(53,562)(64,334)
Net assets(6,601)(8,171)
Capital and reserves
Called up share capital11
Profit and loss account(6,602)(8,172)
Shareholders' funds(6,601)(8,171)
The financial statements were approved and authorised for issue by the Director on 14 April 2026, and are signed on its behalf by:
EREL-SIDERAS, Piril
Director
Registered Company No. 11708928
PIRIL SIDERAS AESTHETICS & SKIN SANCTUARY LTD
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings20
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Fixtures & fittings

Total

££
Cost or valuation
At 01 January 251,1991,199
At 31 December 251,1991,199
Depreciation and impairment
At 01 January 25432432
Charge for year153153
At 31 December 25585585
Net book value
At 31 December 25614614
At 31 December 24767767
4.Stocks

2025

2024

££
Finished goods7,6055,350
Total7,6055,350
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables8,0848,909
Taxation and social security-1,511
Total8,08410,420
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts53,56264,334
Total53,56264,334